✦ LIBER ✦

Persistence of weekly alendronate: a real-world study in Croatia

✍ Scribed by Simeon Grazio; Durda Babic-Naglic; Tatjana Kehler; Bozidar Curkovic

Book ID: 106265132
Publisher: Springer
Year: 2008
Tongue: English
Weight: 76 KB
Volume: 27
Category: Article
ISSN: 0770-3198
DOI: 10.1007/s10067-007-0827-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic effects of alendronate 35 mg

Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study

✍ Shinji Uchida; Tadaaki Taniguchi; Takafumi Shimizu; Taro Kakikawa; Kotoba Okuyam 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 721 KB

Topiramate vs Divalproex Sodium in the P

Topiramate vs Divalproex Sodium in the Preventive Treatment of Migraine: A Prospective “Real-World” Study

✍ Abouch V. Krymchantowski; Carla C. Jevoux 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Efficacy and safety of a once-yearly i.v

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study

✍ Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 216 KB

## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a once‐yearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi

Prognostic utility of T-wave alternans i

Prognostic utility of T-wave alternans in a real-world population of patients with left ventricular dysfunction: the PREVENT-SCD study

✍ Satoshi Shizuta; Kenji Ando; Masakiyo Nobuyoshi; Takanori Ikeda; Hideaki Yoshino 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 264 KB

Clinical usefulness of the Driver®stent

Clinical usefulness of the Driver®stent in a retrospective, collaborative, multicenter, open-label study in Japanese real-world patients with coronary artery disease and the drug-eluting stent era

✍ Shinsuke Nanto; Masaki Awata; Hideki Shimomura; Takatoshi Hayashi; Shinjo Sonoda 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 177 KB

Outcome in the real-world of coronary hi

Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID)—A single-center study comparing Cypher™ sirolimus-eluting with Taxus™ paclitaxel-eluting stents

✍ S. Kumar; V. Suresh; B.D. Prendergast; N.H. Brooks; P. Wicks; R.D. Levy; S.G. Ra 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views